Anal Fistula Treatment Market – Overview
Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. This report analyzes the current and future prospects of the global anal fistula treatment market based on treatment type, application, end-user, and region.
This study is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the revenue of the global anal fistula treatment market in the near future. Primary research formed the bulk of the research efforts, with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation, and various international and national databases. The report provides estimated market size in US$ Mn for treatment type, application, end-user, and region for the period of 2018 to 2026.
Request Brochure for Report –
Anal Fistula Treatment Market – Snapshot
Anal fistula is a tunnel or tract between the epithelial surface of the rectum or anus and the skin i.e., perianal area. This tract can develop infection causing swelling, pus, and pain. The global anal fistula treatment market was valued at US$ 550 Mn in 2017 and is anticipated to expand at a CAGR of 4% from 2018 to 2026 to reach US$ 800 Mn by 2026. High incidence rate of anal fistula and recurrence rate of treated cases have led to a large patient pool. Moreover, increase in incidence of anal fistula inducing co-morbidities such as Crohn’s disease, anal abscess, HIV, and TB infections have resulted in new complex anal fistula cases. Rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects is inducing key industry players to introduce advanced drugs and devices. These include under trial collagen paste for blocking and removing fistula tract, adipose stem cell therapy for anal fistula treatment in Crohn’s disease, video-assisted anal fistula treatment (VAAFT) devices, and laser energy-based devices for anal fistula. However, high cost of treatment and lack of awareness about anal fistula treatment are likely to restrain the global anal fistula treatment market during the forecast period.
High unmet needs in the global anal fistula treatment market present lucrative opportunities for existing players and new entrants. Examples of recent developments in the field are anal fistula tool comprising a channel for anal fistula treatment Queen Mary University of London, by January 2018, Implantable prosthesis for anal fistula treatment by C.R. Bard (acquired by BD) in February 2018, Seton stringing device for anal fistula treatment by Changshu No.2 People’s Hospital in June 2017, innovation of elastic thread for drawing thread in perianal abscess and anal fistula treatment by First Affiliated Hospital of Jiaoning University of Traditional Chinese Medicine in June 2017 and others.
Request for Analysis of COVID19 Impact on Anal Fistula Treatment Market –
Global Anal Fistula Treatment Market: Regional Outlook
North America accounted for the largest share of the global anal fistula treatment market in 2017, followed by Europe. North America’s dominance of the global market is due to early adoption of new technologies and high health care expenditure by the public and private sectors in the U.S. Growth of the anal fistula treatment market in the country is also attributed to high prevalence of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. According to the Crohn’s & Colitis Foundation of America (CCFA), nearly 1.6 million people in the U.S. had IBD in 2014, which includes 780,000 people with Crohn’s disease and 907,000 with ulcerative colitis. Approximately 70,000 new cases of IBD are diagnosed in the country each year. It is estimated that around 35% people with Crohn’s disease develop anal fistula. On the other hand, key players prefer to introduce new treatment tools in Europe. For instance, TiGenix & Takeda Pharmaceutical introduced adipose stem cell-based therapy in March 2018. Medtronic plc is conducting trials for its collagen paste Permacol in Europe. New product launches and their adoption are likely to fuel the market in the region.
Global Anal Fistula Treatment Market: Key Players
The report also profiles major players in the global anal fistula treatment market in terms of key attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Becton, Dickinson and Company, biolitec AG, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, and TiGenix NV. Inorganic growth strategies and business collaborations were the primary strategies adopted by the major players to cement their position in the global anal fistula treatment market.
Buy Anal Fistula Treatment Market Report –
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453